- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 15/62 - Séquences d'ADN codant pour des protéines de fusion
Détention brevets de la classe C12N 15/62
Brevets de cette classe: 10219
Historique des publications depuis 10 ans
|
202
|
316
|
371
|
646
|
537
|
592
|
798
|
846
|
764
|
745
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 20289 |
150 |
| The Trustees of the University of Pennsylvania | 4384 |
83 |
| President and Fellows of Harvard College | 6036 |
74 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2911 |
71 |
| The Board of Trustees of the Leland Stanford Junior University | 6535 |
58 |
| The General Hospital Corporation | 4797 |
57 |
| Regeneron Pharmaceuticals, Inc. | 4444 |
56 |
| Sangamo Therapeutics, Inc. | 419 |
56 |
| The Broad Institute, Inc. | 1870 |
54 |
| Centre National de La Recherche Scientifique | 10693 |
48 |
| National Research Council of Canada | 1559 |
42 |
| F. Hoffmann-La Roche AG | 7933 |
40 |
| Board of Regents, The University of Texas System | 5938 |
39 |
| Massachusetts Institute of Technology | 10143 |
38 |
| The Johns Hopkins University | 5751 |
35 |
| Novartis AG | 10623 |
34 |
| JCR Pharmaceuticals Co., Ltd. | 220 |
34 |
| Immatics Biotechnologies GmbH | 1158 |
32 |
| Monsanto Technology LLC | 8271 |
31 |
| University of Washington | 2380 |
31 |
| Autres propriétaires | 9156 |